ProCE Banner Activity

CAR T Cells and Investigational Bispecific Antibodies in MM

Slideset Download
Download these expert-selected slides on current and investigational anti-BCMA CAR T-cell and bispecific therapies for relapsed/refractory multiple myeloma.

Released: June 07, 2022

Expiration: June 06, 2023

Share

Faculty

Noopur Raje

Noopur Raje, MD

Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

GlaxoSmithKline

Janssen administered by Scientific Affairs

Karyopharm Therapeutics

Regeneron Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Noopur Raje, MD

Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Boston, Massachusetts